Abstract:The implementation of antiretroviral therapy (ART) has effectively restricted the transmission of Human Immunodeficiency Virus (HIV) and improved overall clinical outcomes. However, a complete cure for HIV remains out of reach, as the virus persists in a stable pool of infected cell reservoir that is resistant to therapy and thus a main barrier towards complete elimination of viral infection. While the mechanisms by which host proteins govern viral gene expression and latency are well-studied, the emerging regulatory functions of non-coding RNAs (ncRNA) in the context of T cell activation, HIV gene expression and viral latency have not yet been thoroughly explored. Here, we report the identification of the Cytoskeleton Regulator (CYTOR) long non-coding RNA (lncRNA) as an activator of HIV gene expression that is upregulated following T cell stimulation. Functional studies show that CYTOR suppresses viral latency by directly binding to the HIV promoter and associating with the cellular positive transcription elongation factor (P-TEFb) to activate viral gene expression. CYTOR also plays a global role in regulating cellular gene expression, including those involved in controlling actin dynamics. Depletion of CYTOR expression reduces cytoplasmic actin polymerization in response to T cell activation. In addition, treating HIV-infected cells with pharmacological inhibitors of actin polymerization reduces HIV gene expression. We conclude that both direct and indirect effects of CYTOR regulate HIV gene expression. A complete cure against HIV infection remains elusive, as the virus persists in stable cell reservoirs that are resistant to antiretroviral therapy. While the mechanisms by which host proteins govern viral gene expression and latency are extensively studied, the emerging regulatory roles of non-coding RNAs (ncRNA) in the context of T cell activation, HIV gene expression, and viral latency are less understood. We report the identification of novel ncRNAs that potentially play a role in regulating HIV gene expression in response to T-cell activation. Our work demonstrates that the Cytoskeleton Regulator (CYTOR) long non-coding RNA (lncRNA) exhibits a profound shift in RNA levels upon T-cell stimulation. Functional studies further reveal that CYTOR enhances HIV gene expression and prevents latency establishment following T cell stimulation. CYTOR directly binds to the HIV promoter and associates with the cellular positive transcription machinery to enhance viral gene expression. CYTOR also plays a global role in regulating cellular gene expression, including genes that are involved in the regulation of actin dynamics. Depletion of CYTOR reduces cytoplasmic actin polymerization in response to T cell stimulation. Increasing CYTOR levels did not alter the actin morphology formed in response to TCR activation. Concurrently, pharmacological inhibition of actin polymerization induced by T-cell activation reduces HIV gene expression.

JAK/STAT signaling pathway affects CCR5 expression in human CD4 + T cells

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

Chemokine Receptor Ccr5 Functionally Couples to Inhibitory G Proteins and Undergoes Desensitization

Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor [alpha] expression and limited signal transducers and activators of transcription signaling in response to IL-7 among [gamma]-chain cytokines in HIV patients

Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection

124 CCR6 Ligands Inhibit HIV in Highly Susceptible CD4+CCR6+ T Cells by Inducing APOBEC3G Expression

CCR5 Editing by Staphylococcus Aureus Cas9 in Human Primary CD4+ T Cells and Hematopoietic Stem/progenitor Cells Promotes HIV-1 Resistance and CD4+ T Cell Enrichment in Humanized Mice

Host genetic variants regulates CCR5 expression on immune cells: a study in people living with HIV and healthy controls

In Vitro Immunological Effects of Blocking CCR5 on T Cells

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair

HIV-1 Downregulates the Expression and Phosphorylation of Receptor Tyrosine Kinase by Targeting the NF-κB Pathway

Regulation of CC Chemokine Receptor 5 and CD4 Expression and Human Immunodeficiency Virus Type 1 Replication in Human Macrophages and Microglia by T Helper Type 2 Cytokines.

p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

Regulation of IL-10 expression and function by JAK-STAT in CD8 + T cells

CCR6 ligands inhibit HIV by inducing APOBEC3G.

CCR5 Knockout Prevents Neuronal Injury and Behavioral Impairment Induced in a Transgenic Mouse Model by a CXCR4-Using HIV-1 Glycoprotein 120

Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression

Inhibitory receptor CD47 binding to plasma TSP1 suppresses NK-cell IFN-γ production via activating the JAK/STAT3 pathway during HIV infection

Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection

Genome-wide CRISPR/Cas9 screen reveals JunB downmodulation of HIV co-receptor CXCR4